← 返回

面向精准肿瘤学的体内 CAR-T 细胞治疗昼夜节律工程

英文原题:Circadian engineering of in vivo CAR T cell therapy for precision oncology.

查看英文原题

Circadian engineering of in vivo CAR T cell therapy for precision oncology.

PubMed 2026/05/14(内容时间) NPJ Precis Oncol Q1 · IF 9.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

昼夜节律通过调节内分泌信号、血管通透性、白细胞迁移、代谢以及肿瘤微环境的免疫抑制特征,在 24 小时周期内塑造抗肿瘤免疫。本综述提出,生物学时间可能是 CAR-T 细胞疗法设计中的一个重要变量。该概念对体内 CAR-T 平台尤其相关,因为此类平台可通过可重复诱导、可调节幅度和可逆关闭,将时间控制扩展至输注时机之外。作者讨论的证据显示,CD8 T 细胞的内在时钟、神经内分泌振荡、内皮细胞把关以及肿瘤微环境的节律性重塑,会影响免疫细胞进入、效应能力、耗竭风险和炎症毒性。综述还考察病毒载体、脂质纳米颗粒和可编程控制线路如何支持考虑昼夜节律的 CAR 安装与工作周期调控。总体而言,这些观察支持将“昼夜节律合成 CAR-T”作为一种可检验的转化研究框架,用于精准免疫肿瘤学。

展开英文摘要原文

Circadian rhythms shape antitumor immunity by regulating endocrine signaling, vascular permissiveness, leukocyte trafficking, metabolism, and suppressive features of the tumor microenvironment across the 24-h cycle.

Here, we propose that biological time may represent an important design variable for CAR T-cell therapy. This concept may be particularly relevant to in vivo CAR T platforms, which could extend temporal control beyond infusion timing through repeatable induction, tunable amplitude, and reversible shutdown.

We discuss evidence that CD8 T-cell clocks, neuroendocrine oscillations, endothelial gatekeeping, and rhythmic tumor-microenvironment remodeling influence immune access, effector competence, exhaustion risk, and inflammatory toxicity.

We further examine how viral vectors, lipid nanoparticles, and programmable control circuits might enable circadian-aware CAR installation and duty-cycling.

Together, these observations support chrono-synthetic CAR T as a testable translational framework for precision immuno-oncology.

论文信息

作者
Bautista J、Echeverría CE、Rodríguez-Marcano MG、López-Cortés A
第一作者单位
Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
通讯作者单位
Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. aalc84@gmail.com.
文献类型
综述
期刊
NPJ precision oncology2026 May 14
原文标识
PubMed 42129307 · DOI 10.1038/s41698-026-01464-4